3K3

5-({(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl}oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one


Toggle HydrogenToggle Labels

Chemical Component Summary

Name5-({(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl}oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one
Identifiers5-[[(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one
FormulaC25 H17 F3 N4 O3
Molecular Weight478.423
TypeNON-POLYMER
Isomeric SMILESc1cc2c(cc1C(F)(F)F)nc([nH]2)[C@H]3[C@H]4[C@@H]3Oc5c4cc(cc5)Oc6ccnc7c6CCC(=O)N7
InChIInChI=1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1
InChIKeyNGFFVZQXSRKHBM-FKBYEOEOSA-N

Chemical Details

Formal Charge0
Atom Count52
Chiral Atom Count3
Bond Count58
Aromatic Bond Count22

Drug Info: DrugBank

DrugBank IDDB14773 
NameLifirafenib
Groups investigational
DescriptionLifirafenib is under investigation in clinical trial NCT03641586 (The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor).
SynonymsLifirafenib
CategoriesHeterocyclic Compounds, Fused-Ring
CAS number1446090-79-4

Related Resource References

Resource NameReference
Pharos CHEMBL4209157
PubChem 89670174
ChEMBL CHEMBL4209157